1. Real‐world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi‐centre UK experience. (17th February 2017) Authors: Maciocia, Nicola; Melville, Andrew; Cheesman, Simon; Sharpley, Faye; Ramasamy, Karthik; Streetly, Matthew; Jenner, Matthew; Benjamin, Reuben; Schey, Steve; Maciocia, Paul; Popat, Rakesh; D'sa, Shirley; Rismani, Ali; Cerner, Aviva; Yong, Kwee; Rabin, Neil Journal: British journal of haematology Issue: Volume 176:Number 6(2017) Page Start: 908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗